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Slingshot to the lamellipod
 
he actin cytoskeleton at the front of migrating cells is an ever-changing 
species. Although actin is polymerized in the lamellipod, the filaments 
that are built remain dynamic. Their turnover is mediated by cofilin, which 
stimulates filament disassembly at or near the pointed ends, thus providing 
monomers for further polymerization. On page 465, Nagata-Ohashi et al. 
show that actin filaments take care of their own dynamic behavior via 
Slingshot-1L (SSH1L), a phosphatase that activates cofilin.
In vitro, F-actin activated SSH1L 10-fold. Migrating epithelial cells 
accumulated SSH1L (and thus dephosphorylated and active cofilin) in the 
T
 
lamellipod, and this depended on an intact actin assembly.
To bind to F-actin and activate cofilin, SSH1L must 
first be released from an interaction with 14–3-3 proteins, 
which sequester SSH1L in the cytoplasm. SSH1L 
escaped this interaction when it was dephosphorylated. 
This dephosphorylation could be induced with the 
extracellular migratory signal, NRG.
Restricting SSH1L activity to the F-actin–rich lamelli-
pod may help to maintain polarized migration by allowing 
more stable actin structures, such as stress fibers, to persist 
at the rear of the cell. Cofilin was recently shown to be 
capable of defining the direction of cell migration (Ghosh 
et al. 
 
Science
 
. 304:743–746). Now, the authors need to 
determine whether this function requires the F-actin–
mediated activation of SSH1L.
 
 
 
 
SSH1L (blue) moves 
to the lamellipod 
when cells are in-
duced to migrate 
(bottom).
 
NG2
 
 
 
 cells feed the brain
 
he brain is a rapidly changing landscape. After birth, 
its alterations require a source of progenitors that 
can form different cell types. In an attempt to characterize 
these progenitors, Aguirre et al. (page 575) have
identified a population of neural stem cells (NSCs) that 
make inhibitory neurons in the postnatal mouse brain.
Neurogenesis is common in an area of the brain 
known as the subventricular zone (SVZ), so this seemed 
like a likely place to find NSCs. The same laboratory 
had previously shown that cells expressing the NG2 
proteoglycan, once thought to give rise only to oligo-
dendrocytes, could form active neurons in vitro. They 
now find that a portion of NG2-expressing cells that 
reside in the SVZ are these NSCs, which contribute 
to neurogenesis in the postnatal brain.
Some of the SVZ NG2
 
 
 
 cells also expressed proteins 
that mark stem cell populations. These cells were the pro-
genitors of hippocampal neurons. The group isolated 
NG2
 
 
 
 cells from the brain of one mouse and transplanted 
them into the lateral ventricle of a host mouse. Weeks 
later, progeny of the transplanted cells that ended up in 
the white matter had formed oligodendrocytes. But those 
that found their way to the hippocampus had become 
fully functional and integrated inhibitory interneurons.
The inhibitory neurons formed by NG2
 
 
 
 NSCs are 
the same type of cells that degenerate in a common child-
hood form of epilepsy. The next step is to determine 
whether transplanted NG2
 
 
 
 cells can regenerate these 
lost neurons in a mouse model of the disease.
 
 
 
 
T
Transplanted NG2
  cells (green) become functional 
inhibitory interneurons.
 
Geminin halts DNA synthesis
 
nce is enough when it comes to DNA replication—for every 
cell cycle, chromosomes are replicated just one time to prevent 
genomic instability. On page 473, Melixetian et al. identify a
protein that polices this limitation in human cells.
The replication police officer is 
Geminin, which prevents replication 
origins in 
 
Xenopus
 
 from recruiting 
licensing proteins that can give the 
replication go-ahead. In frogs, 
Geminin does not work alone, as 
its loss does not induce rereplication. 
But in human cells, the authors find, 
Geminin runs the show.
RNAi of Geminin led to additional 
rounds of replication in both normal and cancerous human cell lines. 
Rereplication required licensing proteins, suggesting that Geminin 
works in mammalian cells as it does in frogs.
Rereplicating cells accumulated foci of proteins that bind to double-
stranded DNA breaks. The foci might be a result of colliding replication 
forks that are recognized as breaks. Whatever their genesis, they 
resulted in activation of the DNA damage checkpoint controlled by 
the CHK1 kinase, thus preventing entry into mitosis.
If the checkpoint was then turned off, the cells entered mitosis but 
died before division was complete. If cells lacking Geminin could 
somehow escape the checkpoint and yet survive (through other 
unknown mutations), they would be a cancerous nightmare, complete 
with genomic instability and uncontrolled proliferation. 
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Loss of Geminin leads to multiple 
copies of the  -globin gene (red).
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